chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, Vaccination site lymphadenopathy, Vaccination site swelling
Clinical narrative: still are not feeling quite back to normal; lump the size of a softball, that was injected; fatigue; chills; fever; a swollen armpit under the arm that was injected; body aches; could not bend fingers; hard time sleeping that night due to fever; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (could not bend fingers), INSOMNIA (hard time sleeping that night due to fever), FEELING ABNORMAL (still are not feeling quite back to normal), VACCINATION SITE LYMPHADENOPATHY (lump the size of a softball, that was injected) and FATIGUE (fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in November 2020.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (could not bend fingers), INSOMNIA (hard time sleeping that night due to fever), VACCINATION SITE LYMPHADENOPATHY (lump the size of a softball, that was injected), FATIGUE (fatigue), CHILLS (chills), PYREXIA (fever), VACCINATION SITE SWELLING (a swollen armpit under the arm that was injected) and MYALGIA (body aches). On 12-Apr-2021, the patient experienced FEELING ABNORMAL (still are not feeling quite back to normal). At the time of the report, MUSCULOSKELETAL STIFFNESS (could not bend fingers), INSOMNIA (hard time sleeping that night due to fever), FEELING ABNORMAL (still are not feeling quite back to normal), VACCINATION SITE LYMPHADENOPATHY (lump the size of a softball, that was injected), FATIGUE (fatigue), CHILLS (chills), PYREXIA (fever), VACCINATION SITE SWELLING (a swollen armpit under the arm that was injected) and MYALGIA (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD21-073728 (E2B Linked Report).; Sender's Comments:  MOD21-073728:CROSSLINKED
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Lip swelling, Rash, Rash erythematous, Swelling
Clinical narrative: Swollen Lips after 2nd dose; Rash all over the body which is red, swollen, comes and does on different parts of body; Rash all over the body which is red and swollen; Rash all over the body; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (Swollen Lips after 2nd dose), RASH ERYTHEMATOUS (Rash all over the body which is red, swollen, comes and does on different parts of body), SWELLING (Rash all over the body which is red and swollen) and RASH (Rash all over the body) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced LIP SWELLING (Swollen Lips after 2nd dose), RASH ERYTHEMATOUS (Rash all over the body which is red, swollen, comes and does on different parts of body), SWELLING (Rash all over the body which is red and swollen) and RASH (Rash all over the body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of 1 dosage form; PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1 dosage form and FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Adverse event, at a dose of 1 dosage form. On 14-Feb-2021, LIP SWELLING (Swollen Lips after 2nd dose) had resolved. On 03-Mar-2021, RASH ERYTHEMATOUS (Rash all over the body which is red, swollen, comes and does on different parts of body), SWELLING (Rash all over the body which is red and swollen) and RASH (Rash all over the body) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Patient reported that treatment with Allegra was not helping    This case was linked to US-MODERNATX, INC.-MOD-2021-074816 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-074816:First dose case
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Rash, Rash pruritic, Swelling
Clinical narrative: Swollen face; big itchy swollen patches on her whole body; dizziness; weakness; itchy swollen patches on her whole body; patches on her whole body; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Swollen face), SWELLING (big itchy swollen patches on her whole body), DIZZINESS (dizziness), ASTHENIA (weakness) and RASH PRURITIC (itchy swollen patches on her whole body) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No past medical history was reported.  Concomitant products included LEVOTHYROXINE SODIUM (EUTHYROX) for an unknown indication.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced SWELLING FACE (Swollen face), SWELLING (big itchy swollen patches on her whole body), DIZZINESS (dizziness), ASTHENIA (weakness), RASH PRURITIC (itchy swollen patches on her whole body) and RASH (patches on her whole body). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Adverse event, at an unspecified dose and frequency. At the time of the report, SWELLING FACE (Swollen face), SWELLING (big itchy swollen patches on her whole body), DIZZINESS (dizziness), ASTHENIA (weakness), RASH PRURITIC (itchy swollen patches on her whole body) and RASH (patches on her whole body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: Swollen face; big itchy swollen patches on her whole body; dizziness; weakness; itchy swollen patches on her whole body; patches on her whole body; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Swollen face), SWELLING (big itchy swollen patches on her whole body), DIZZINESS (dizziness), ASTHENIA (weakness) and RASH PRURITIC (itchy swollen patches on her whole body) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No past medical history was reported.  Concomitant products included LEVOTHYROXINE SODIUM (EUTHYROX) for an unknown indication.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced SWELLING FACE (Swollen face), SWELLING (big itchy swollen patches on her whole body), DIZZINESS (dizziness), ASTHENIA (weakness), RASH PRURITIC (itchy swollen patches on her whole body) and RASH (patches on her whole body). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Adverse event, at an unspecified dose and frequency. At the time of the report, SWELLING FACE (Swollen face), SWELLING (big itchy swollen patches on her whole body), DIZZINESS (dizziness), ASTHENIA (weakness), RASH PRURITIC (itchy swollen patches on her whole body) and RASH (patches on her whole body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: slight breathing issue; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (slight breathing issue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     Concurrent medical conditions included Shellfish allergy, Arthropod sting (beestings) and Drug allergy (some antibiotics). Concomitant products included LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for an unknown indication.   On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Mar-2021, the patient experienced DYSPNOEA (slight breathing issue). On 07-Mar-2021, DYSPNOEA (slight breathing issue) had resolved.            Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-074866 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-074866:MOD-2021-074866 (Case for dose 2)
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Lymphadenopathy
Clinical narrative: pain underneath her arm; swelling underneath her arm; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (pain underneath her arm) and LYMPHADENOPATHY (swelling underneath her arm) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced AXILLARY PAIN (pain underneath her arm) and LYMPHADENOPATHY (swelling underneath her arm). At the time of the report, AXILLARY PAIN (pain underneath her arm) and LYMPHADENOPATHY (swelling underneath her arm) outcome was unknown. Not Provided          No concomitant medications were reported.  No treatment information was reported.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Rash
Clinical narrative: Lymph node under her breast/armpits; rash; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Lymph node under her breast/armpits) and RASH (rash) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No historical conditions were reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (Lymph node under her breast/armpits) and RASH (rash). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) for Rash, at an unspecified dose and frequency. At the time of the report, LYMPHADENOPATHY (Lymph node under her breast/armpits) and RASH (rash) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drugs were reported.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dyspnoea, Vaccination site pruritus, Wheezing
Clinical narrative: difficulty breathing; wheezing; overall weakness; itching on the vaccinated arm; This spontaneous case was reported by a pharmacist and describes the occurrence of DYSPNOEA (difficulty breathing), WHEEZING (wheezing), ASTHENIA (overall weakness) and VACCINATION SITE PRURITUS (itching on the vaccinated arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (difficulty breathing), WHEEZING (wheezing), ASTHENIA (overall weakness) and VACCINATION SITE PRURITUS (itching on the vaccinated arm). At the time of the report, DYSPNOEA (difficulty breathing), WHEEZING (wheezing), ASTHENIA (overall weakness) and VACCINATION SITE PRURITUS (itching on the vaccinated arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Patient was enrolled in Johnson and Johnson vaccine clinical trial and received one dose of the vaccine but patient thought he got a placebo.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: when it woke up saw the bleeding from the nose; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (when I woke up saw the bleeding from the nose) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. HRSTE372A1B) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced EPISTAXIS (when I woke up saw the bleeding from the nose). At the time of the report, EPISTAXIS (when I woke up saw the bleeding from the nose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Influenza, Nasopharyngitis
Clinical narrative: cold; flu; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold) and INFLUENZA (flu) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (cold) and INFLUENZA (flu). At the time of the report, NASOPHARYNGITIS (cold) and INFLUENZA (flu) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported.
Age: 16.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 16 year old inadvertently received Modern COVID-19 vaccine; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old inadvertently received Modern COVID-19 vaccine) in a 16-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old inadvertently received Modern COVID-19 vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old inadvertently received Modern COVID-19 vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  Treatment information was not provided.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: itching on her body; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Apr-2021. The most recent information was received on 06-Aug-2021 and was forwarded to Moderna on 06-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching on her body) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced PRURITUS (itching on her body). At the time of the report, PRURITUS (itching on her body) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided.  Treatment information was not provided.  Per report, the itching lasted for about three and a half weeks before resolution. The patient reported experiencing no adverse events after receiving her second dose of  the Moderna COVID-19 vaccination.   Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Follow-up received and event outcome was updated from unknown to recovered/resolved
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Diarrhoea, Nasopharyngitis, Neuralgia
Clinical narrative: diarrhea; cramps in stomach; cold; pain in her leg; pinch in her belly button; chills; This spontaneous case was reported by a patient family member or friend and describes the occurrence of DIARRHOEA (diarrhea), ABDOMINAL PAIN UPPER (cramps in stomach), NASOPHARYNGITIS (cold), PAIN IN EXTREMITY (pain in her leg) and NEURALGIA (pinch in her belly button) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced DIARRHOEA (diarrhea), ABDOMINAL PAIN UPPER (cramps in stomach), NASOPHARYNGITIS (cold), PAIN IN EXTREMITY (pain in her leg), NEURALGIA (pinch in her belly button) and CHILLS (chills). At the time of the report, DIARRHOEA (diarrhea), ABDOMINAL PAIN UPPER (cramps in stomach), NASOPHARYNGITIS (cold), PAIN IN EXTREMITY (pain in her leg), NEURALGIA (pinch in her belly button) and CHILLS (chills) outcome was unknown.            No relevant concomitant medications were reported.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: diarrhea; cramps in stomach; cold; pain in her leg; pinch in her belly button; chills; This spontaneous case was reported by a patient family member or friend and describes the occurrence of DIARRHOEA (diarrhea), ABDOMINAL PAIN UPPER (cramps in stomach), NASOPHARYNGITIS (cold), PAIN IN EXTREMITY (pain in her leg) and NEURALGIA (pinch in her belly button) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced DIARRHOEA (diarrhea), ABDOMINAL PAIN UPPER (cramps in stomach), NASOPHARYNGITIS (cold), PAIN IN EXTREMITY (pain in her leg), NEURALGIA (pinch in her belly button) and CHILLS (chills). At the time of the report, DIARRHOEA (diarrhea), ABDOMINAL PAIN UPPER (cramps in stomach), NASOPHARYNGITIS (cold), PAIN IN EXTREMITY (pain in her leg), NEURALGIA (pinch in her belly button) and CHILLS (chills) outcome was unknown.            No relevant concomitant medications were reported.  Treatment information was not provided.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Headache, Pain, Pain in extremity, Pyrexia
Clinical narrative: cough; body ache; fever; headache; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), COUGH (cough), PAIN (body ache), PYREXIA (fever) and HEADACHE (headache) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 002B21A) for COVID-19 vaccination.     The patient's past medical history included Exposure to COVID-19 in April 2021.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm), PAIN (body ache), PYREXIA (fever) and HEADACHE (headache). On 12-Apr-2021, the patient experienced COUGH (cough). At the time of the report, PAIN IN EXTREMITY (sore arm), COUGH (cough), PAIN (body ache), PYREXIA (fever) and HEADACHE (headache) outcome was unknown.            On unknown date, Covid test was performed on patient with negative results.  No relevant concomitant medications were reported.  Treatment information was not provided.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Fall, Fatigue, Headache
Clinical narrative: falling down; severe joint pain; fatigue; headache; Severe pain; dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), FALL (falling down), PAIN (Severe pain), ARTHRALGIA (severe joint pain) and FATIGUE (fatigue) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced DIZZINESS (dizziness), PAIN (Severe pain), FATIGUE (fatigue) and HEADACHE (headache). On 30-Mar-2021, the patient experienced FALL (falling down) and ARTHRALGIA (severe joint pain). The patient was treated with IBUPROFEN for Pain, at a dose of 1 dosage form. At the time of the report, DIZZINESS (dizziness), FALL (falling down), PAIN (Severe pain), ARTHRALGIA (severe joint pain), FATIGUE (fatigue) and HEADACHE (headache) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were reported.       Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 30-May-2021: The patient information, vaccine lot number and additional event were updated.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: falling down; severe joint pain; fatigue; headache; Severe pain; dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), FALL (falling down), PAIN (Severe pain), ARTHRALGIA (severe joint pain) and FATIGUE (fatigue) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced DIZZINESS (dizziness), PAIN (Severe pain), FATIGUE (fatigue) and HEADACHE (headache). On 30-Mar-2021, the patient experienced FALL (falling down) and ARTHRALGIA (severe joint pain). The patient was treated with IBUPROFEN for Pain, at a dose of 1 dosage form. At the time of the report, DIZZINESS (dizziness), FALL (falling down), PAIN (Severe pain), ARTHRALGIA (severe joint pain), FATIGUE (fatigue) and HEADACHE (headache) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were reported.       Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 30-May-2021: The patient information, vaccine lot number and additional event were updated.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Malaise, Musculoskeletal discomfort, Vaccination site pain
Clinical narrative: When I woke up this morning, when I turned my head right or left I had a problem; didn't feel great the next day; arm very sore that day; dizziness; diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), DIARRHOEA (diarrhea), MALAISE (didn't feel great the next day), VACCINATION SITE PAIN (arm very sore that day) and MUSCULOSKELETAL DISCOMFORT (When I woke up this morning, when I turned my head right or left I had a problem) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 03M20A and 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hearing aid user.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced DIZZINESS (dizziness), DIARRHOEA (diarrhea) and VACCINATION SITE PAIN (arm very sore that day). On 19-Feb-2021, the patient experienced MALAISE (didn't feel great the next day). On 13-Apr-2021, the patient experienced MUSCULOSKELETAL DISCOMFORT (When I woke up this morning, when I turned my head right or left I had a problem). At the time of the report, DIZZINESS (dizziness), DIARRHOEA (diarrhea), MALAISE (didn't feel great the next day), VACCINATION SITE PAIN (arm very sore that day) and MUSCULOSKELETAL DISCOMFORT (When I woke up this morning, when I turned my head right or left I had a problem) had not resolved.            No relevant concomitant medications were reported. Treatment information was not provided. Patient stated that side effects they had were not because of the vaccine but due to their sinus problem.   Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: TCR attached included the causal relationship the adverse event and drug. Patient denied further follow up.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Pain in extremity, Paraesthesia, Somnolence
Clinical narrative: weird muscle cramps /muscle cramps are almost like spasms; pain in the legs; tingling in the hands and feet/vibrating/tingling feeling in her arms and legs; more sleepy; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (weird muscle cramps /muscle cramps are almost like spasms), PAIN IN EXTREMITY (pain in the legs), PARAESTHESIA (tingling in the hands and feet/vibrating/tingling feeling in her arms and legs) and SOMNOLENCE (more sleepy) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     Concurrent medical conditions included Primary hyperparathyroidism (Definitively diagnosed 2.5 years ago), Insomnia (Since age 11), Seasonal allergy and Irritable bowel syndrome. Concomitant products included ORAL CONTRACEPTIVE NOS for Birth control, CANNABIDIOL (CBD OIL) for Insomnia, CINACALCET HYDROCHLORIDE (SENSIPAR) for Primary hyperparathyroidism, BISMUTH SUBSALICYLATE (PEPTO-BISMOL), ALPHA-D-GALACTOSIDASE (BEANO), CLARITHROMYCIN, OMEPRAZOLE, TINIDAZOLE (OTC-HP) and CALCIUM CARBONATE (TUMS [CALCIUM CARBONATE]) for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced MUSCLE SPASMS (weird muscle cramps /muscle cramps are almost like spasms), PAIN IN EXTREMITY (pain in the legs), PARAESTHESIA (tingling in the hands and feet/vibrating/tingling feeling in her arms and legs) and SOMNOLENCE (more sleepy). At the time of the report, MUSCLE SPASMS (weird muscle cramps /muscle cramps are almost like spasms), PAIN IN EXTREMITY (pain in the legs), PARAESTHESIA (tingling in the hands and feet/vibrating/tingling feeling in her arms and legs) and SOMNOLENCE (more sleepy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient stated that she had to start adjusting her Sensipar 30 mg daily dose by skipping doses to help regulate the medications affects. The patient was also wondering if her calcium level was too low.  Treatment information was not provided.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Vaccination site pain
Clinical narrative: swelling of lymph node; injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swelling of lymph node) and VACCINATION SITE PAIN (injection site pain) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced LYMPHADENOPATHY (swelling of lymph node) and VACCINATION SITE PAIN (injection site pain). On 16-Mar-2021, LYMPHADENOPATHY (swelling of lymph node) and VACCINATION SITE PAIN (injection site pain) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       The patient experienced injection site pain and swelling of lymph node within 5 to 10 hours following the injection. The patient continued to breastfeed.  No relevant concomitant medications were reported.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Intentional product use issue
Clinical narrative: patient plans to receive second dose 42 days after first dose; This spontaneous case was reported by a consumer and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (patient plans to receive second dose 42 days after first dose) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (patient plans to receive second dose 42 days after first dose). At the time of the report, INTENTIONAL PRODUCT USE ISSUE (patient plans to receive second dose 42 days after first dose) had resolved.            No relevant concomitant medications were reported.  Treatment information was not provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Acne, Dyspnoea, Pruritus, Rash
Clinical narrative: rash is like pimples; ash all over ankles; itchy rash all over body; itchy rash all over body; itching; slight breathing issue; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Apr-2021 and was forwarded to Moderna on 12-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching), the first episode of RASH (itchy rash all over body), ACNE (rash is like pimples), RASH (ash all over ankles) and DYSPNOEA (slight breathing issue) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for an unknown indication.   On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Mar-2021, the patient experienced DYSPNOEA (slight breathing issue). On 06-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRURITUS (itching). On 07-Apr-2021, the patient experienced the first episode of RASH (itchy rash all over body). 07-Apr-2021, the patient experienced the second episode of RASH (itchy rash all over body). On an unknown date, the patient experienced ACNE (rash is like pimples) and RASH (ash all over ankles). On 07-Mar-2021, DYSPNOEA (slight breathing issue) had resolved. At the time of the report, PRURITUS (itching), ACNE (rash is like pimples), RASH (ash all over ankles) and the last episode of RASH (itchy rash all over body) outcome was unknown.            Treatment medications was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-074848 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-074848:MOD-2021-074848 (Case for dose 1)
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Dyspnoea, Myalgia, Nausea
Clinical narrative: shortness of breath; diarrhea; nausea; vomiting; fever; extreme body aches; chills; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), DIARRHOEA (diarrhea), NAUSEA (nausea), VOMITING (vomiting) and PYREXIA (fever) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced DYSPNOEA (shortness of breath). 15-Mar-2021, the patient experienced DIARRHOEA (diarrhea), NAUSEA (nausea), VOMITING (vomiting), PYREXIA (fever), MYALGIA (extreme body aches) and CHILLS (chills). On 29-Mar-2021, DYSPNOEA (shortness of breath), DIARRHOEA (diarrhea), NAUSEA (nausea), VOMITING (vomiting), PYREXIA (fever), MYALGIA (extreme body aches) and CHILLS (chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.   This case was linked to MOD-2021-239360 (Patient Link).
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: shortness of breath; diarrhea; nausea; vomiting; fever; extreme body aches; chills; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), DIARRHOEA (diarrhea), NAUSEA (nausea), VOMITING (vomiting) and PYREXIA (fever) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced DYSPNOEA (shortness of breath). 15-Mar-2021, the patient experienced DIARRHOEA (diarrhea), NAUSEA (nausea), VOMITING (vomiting), PYREXIA (fever), MYALGIA (extreme body aches) and CHILLS (chills). On 29-Mar-2021, DYSPNOEA (shortness of breath), DIARRHOEA (diarrhea), NAUSEA (nausea), VOMITING (vomiting), PYREXIA (fever), MYALGIA (extreme body aches) and CHILLS (chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.   This case was linked to MOD-2021-239360 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VERTIGO. At the time of the report, VERTIGO outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.      No concomitant medications were reported.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Severe shoulder pain; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Severe shoulder pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced ARTHRALGIA (Severe shoulder pain). At the time of the report, ARTHRALGIA (Severe shoulder pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Allergy to vaccine, Back pain, Dizziness, Headache, Hypoaesthesia
Clinical narrative: Migraine; Allergies; Rashes; Lower back pain; Dizziness; Vomited; Severe headache; Numbed left arm; Muscle spasm on the neck; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbed left arm), MUSCLE SPASMS (Muscle spasm on the neck), BACK PAIN (Lower back pain), DIZZINESS (Dizziness) and MIGRAINE (Migraine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced HYPOAESTHESIA (Numbed left arm), MUSCLE SPASMS (Muscle spasm on the neck), MYALGIA (Soreness) and HEADACHE (Severe headache). On 03-Apr-2021, the patient experienced BACK PAIN (Lower back pain), DIZZINESS (Dizziness) and VOMITING (Vomited). On an unknown date, the patient experienced MIGRAINE (Migraine), ALLERGY TO VACCINE (Allergies) and RASH (Rashes). At the time of the report, HYPOAESTHESIA (Numbed left arm), MUSCLE SPASMS (Muscle spasm on the neck), BACK PAIN (Lower back pain), ALLERGY TO VACCINE (Allergies), RASH (Rashes), MYALGIA (Soreness), VOMITING (Vomited) and HEADACHE (Severe headache) outcome was unknown and DIZZINESS (Dizziness) and MIGRAINE (Migraine) had not resolved.            Concomitant product use was not provided. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Follow up received included reporter details and new adverse events.
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Muscle spasms, Myalgia, Rash, Vomiting
Clinical narrative: Migraine; Allergies; Rashes; Lower back pain; Dizziness; Vomited; Severe headache; Numbed left arm; Muscle spasm on the neck; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbed left arm), MUSCLE SPASMS (Muscle spasm on the neck), BACK PAIN (Lower back pain), DIZZINESS (Dizziness) and MIGRAINE (Migraine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced HYPOAESTHESIA (Numbed left arm), MUSCLE SPASMS (Muscle spasm on the neck), MYALGIA (Soreness) and HEADACHE (Severe headache). On 03-Apr-2021, the patient experienced BACK PAIN (Lower back pain), DIZZINESS (Dizziness) and VOMITING (Vomited). On an unknown date, the patient experienced MIGRAINE (Migraine), ALLERGY TO VACCINE (Allergies) and RASH (Rashes). At the time of the report, HYPOAESTHESIA (Numbed left arm), MUSCLE SPASMS (Muscle spasm on the neck), BACK PAIN (Lower back pain), ALLERGY TO VACCINE (Allergies), RASH (Rashes), MYALGIA (Soreness), VOMITING (Vomited) and HEADACHE (Severe headache) outcome was unknown and DIZZINESS (Dizziness) and MIGRAINE (Migraine) had not resolved.            Concomitant product use was not provided. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Follow up received included reporter details and new adverse events.
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Pruritus
Clinical narrative: Itching in legs; Tingling in legs; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching in legs) and PARAESTHESIA (Tingling in legs) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced PRURITUS (Itching in legs) and PARAESTHESIA (Tingling in legs). At the time of the report, PRURITUS (Itching in legs) and PARAESTHESIA (Tingling in legs) outcome was unknown. Not applicable      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Patient gender was updated.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Rash macular, Rash pruritic
Clinical narrative: Itchy Red Spots all over his body; Rash Spreading all over the body / Braking out; Red Itchy Rash appeared on both Arms and Chest; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH PRURITIC (Red Itchy Rash appeared on both Arms and Chest), RASH MACULAR (Itchy Red Spots all over his body) and RASH (Rash Spreading all over the body / Braking out) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced RASH PRURITIC (Red Itchy Rash appeared on both Arms and Chest). On 09-Apr-2021, the patient experienced RASH (Rash Spreading all over the body / Braking out). On 12-Apr-2021, the patient experienced RASH MACULAR (Itchy Red Spots all over his body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, RASH PRURITIC (Red Itchy Rash appeared on both Arms and Chest), RASH MACULAR (Itchy Red Spots all over his body) and RASH (Rash Spreading all over the body / Braking out) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications for the event included two doses of an unknown medicine. No concomitant medication was provided by the reporter. At the Follow-up report the reporter mentioned that it had been 16 weeks post vaccination, he had been to Emergency room thrice and visited his doctor nine times, taking medications twice daily and breaking out once weekly.   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: significant follow-up appended
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache
Clinical narrative: Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache) and CHILLS (Chills). At the time of the report, HEADACHE (Headache) and CHILLS (Chills) had resolved. Not Provided          No concomitant product use was reported  No treatment information was provided   Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: TCR- event outcome updated
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Interchange of vaccine products; This spontaneous case was reported by an other health care professional and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included ALBUTEROL [SALBUTAMOL], LEVOTHYROXINE, METOPROLOL TARTRATE, ATORVASTATIN and CLOPIDOGREL for an unknown indication.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products). On 07-Apr-2021, INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication were provided. No concomitant medication were provided. Action taken for Moderna COVID-19 Vaccine was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 09-Apr-2021: 1st dose and 2nd dose information were updated, concomitant medication were added. Patient information was updated.